Nexium Jury Hears From Walgreen Exec On Generics
A Walgreen Co. executive testified Wednesday at a pay-for-delay trial over AstraZeneca PLC's Nexium that the heartburn treatment did face competition for prescriptions from several other similar drugs, but emphasized that...To view the full article, register now.
Already a subscriber? Click here to view full article